ESC Premium Access

Higher risk of dementia without oral anticoagulation in atrial fibrillation

Congress Presentation

About the speaker

Associate Professor Leif Friberg

Friberg Research, Stockholm (Sweden)
1 presentation
0 follower

9 more presentations in this session

Atrial fibrillation and venous thromboembolism. a Swedish nationwide registry study on 1358274 individuals.

Speaker: Assistant Professor B. Hornestam (Gothenburg, SE)


Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Speaker: Doctor P. Noseworthy (Rochester, US)


Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

Speaker: Doctor P. Noseworthy (Rochester, US)


Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation: need for anticoagulation?

Speaker: Mr J. Butt (Copenhagen, DK)


Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis.

Speaker: Professor L. Fauchier (Tours, FR)


Access the full session

Anticoagulation in atrial fibrillation

Speakers: Associate Professor L. Friberg, Assistant Professor B. Hornestam, Doctor P. Noseworthy, Doctor P. Noseworthy, Mr J. Butt...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb